Table 2 HCMV seroprevalence and HCV and/or HBV infection in the Department of Hepatology.
From: Increased HCMV seroprevalence in patients with hepatocellular carcinoma
Department Hepatology | HCV and/or HBV | Patients | HCMV seropositivity (%) | Age (years, mean) |
|---|---|---|---|---|
Division 1 | Positive | 30 | 80.0 | 49.7 |
| Â | Negative | 34 | 64.7 | 41.3 |
Division 2 | Positive | 49 | 81.6 | 58.5 |
| Â | Negative | 99 | 58.6 | 57.4 |
Division 3 | Positive | 52 | 78.8 | 54.6 |
| Â | Negative | 133 | 57.9 | 55.3 |
Total | Positive | 164 | 76.2 | 55.0 |
| Â | Negative | 446 | 56.5 | 53.3 |